End-of-day quote
Other stock markets
|
||
- EUR | - |
04-25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
04-23 | Transcript : Heidelberg Pharma AG - Special Call |
Chart calendar Wilex AG
Upcoming events on Wilex AG
Past events on Wilex AG
12/05/2024 | PEGS Boston Conference |
25/04/2024 07:00 | Q1 2024 Sales and Revenue Release - Interim Management Statement |
23/04/2024 15:00 | R&D Day |
15/04/2024 | Kempen Life Science Conference |
15/04/2024 | German Biotechnology Conference |
10/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No 7183 |
08/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No 1865 |
08/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No CT067 |
07/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No :LB059 |
04/04/2024 | American Association for Cancer Research Meeting |
25/03/2024 14:00 | Q4 2023 Earnings Call |
25/03/2024 06:10 | Q4 2023 Earnings Release |
11/03/2024 | World ADC Conference |
27/02/2024 | European Life Science CEO Forum |
11/12/2023 02:00 | American Society of Hematology Meeting - Abstract::#3334 |
05/11/2023 | BIO-Europe Conference |
24/10/2023 | Proteomics in Cell Biology and Disease Conference |
15/10/2023 | World ADC Conference |
12/10/2023 06:09 | Q3 2023 Sales and Revenue Release - Interim Management Statement |
09/10/2023 | European Antibody Congress |
Annual results
Fiscal Period | November | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 7,96 8,63 -7.75% | 9,58 9,70 -1.28% | 2,31 2,31 0.13% | 19,9 19,4 2.27% | 16,8 13,8 21.75% | 11,5 |
EBITDA Million EUR | Released Forecast Spread | -9,60 -8,08 -18.83% | -17,6 -15,1 -16.55% | -24,8 -23,2 -7.14% | -16,4 -18,2 9.58% | -20,3 -31,1 34.63% | -22,1 |
EBIT Million EUR | Released Forecast Spread | -10,1 -8,57 -18.4% | -18,3 -15,8 -15.97% | -25,6 -24,6 -4.27% | -17,2 -19,9 13.62% | -21,2 -32,0 33.72% | -22,6 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -10,1 -8,30 -22.21% | -18,3 -14,9 -22.72% | -26,1 -24,7 -5.84% | -17,8 -20,3 12.29% | -20,3 0,00 - | 0,00 |
Net income Million EUR | Released Forecast Spread | -10,1 -8,30 -22.27% | -18,3 -14,9 -22.72% | -26,1 -24,9 -5.04% | -19,7 -20,0 1.67% | -20,3 0,00 - | 0,00 |
EPS EUR | Released Forecast Spread | -0,36 -0,30 -19.44% | -0,61 -0,54 -13.45% | -0,80 -0,72 -10.81% | -0,53 -0,64 17.46% | -0,44 -0,72 38.89% | -0,30 |
Announcement Date | 19/03/20 | 25/03/21 | 24/03/22 | 05/03/23 | 25/03/24 | - |
Past sector events for Wilex AG
17/05/2024 12:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 12:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 06:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
15/05/2024 13:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
14/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
15/05/2024 21:01 | CELCUITY INC.: Q1 2024 Earnings Release |
14/05/2024 21:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 21:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 13:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- HPHA Stock
- Stock
- Calendar Wilex AG